These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1972843)

  • 1. Sézary-type cutaneous T-cell leukaemia. Response to Winkelmann regimen.
    Harland CC; Balsitis M; Millard LG
    Acta Derm Venereol; 1990; 70(3):251-3. PubMed ID: 1972843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma.
    McGinnis KS; Shapiro M; Vittorio CC; Rook AH; Junkins-Hopkins JM
    Arch Dermatol; 2003 Jun; 139(6):771-5. PubMed ID: 12810509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sézary syndrome: treatment with a prednisolone-chlorambucil combination].
    Lorent A; Feermans W; Blondeel A; Meerts P; Achten G
    Dermatologica; 1982 Nov; 165(5):464-5. PubMed ID: 7169121
    [No Abstract]   [Full Text] [Related]  

  • 4. [Extracorporeal photopheresis in the therapy of Sézary syndrome].
    Marschalkó M; Knobler R; Soós G; Berecz M; Pálóczy K; Rácz I
    Orv Hetil; 1993 Jun; 134(23):1253-7. PubMed ID: 8332344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of Sézary syndrome.
    Winkelmann RK; Diaz-Perez JL; Buechner SA
    J Am Acad Dermatol; 1984 Jun; 10(6):1000-4. PubMed ID: 6736317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of retinoids and PUVA (Re-PUVA) in the treatment of cutaneous T cell lymphomas.
    Serri F; De Simone C; Venier A; Rusciani L; Marchetti F
    Curr Probl Dermatol; 1990; 19():252-7. PubMed ID: 2404681
    [No Abstract]   [Full Text] [Related]  

  • 7. [The Sézary syndrome].
    Ferreira F; Correia TM; Callabro L; Andrade J
    Acta Med Port; 1998 Dec; 11(12):1135-9. PubMed ID: 10192992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sézary syndrome in an 11-year-old girl.
    Meister L; Duarte AM; Davis J; Perez JL; Schachner LA
    J Am Acad Dermatol; 1993 Jan; 28(1):93-5. PubMed ID: 8425978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained remission of Sézary syndrome.
    Bouwhuis SA; McEvoy MT; Davis MD
    Eur J Dermatol; 2002; 12(3):287-90. PubMed ID: 11978575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of erythrodermic cutaneous T-cell lymphoma with intermittent chlorambucil and fluocortolone therapy.
    Coors EA; von den Driesch P
    Br J Dermatol; 2000 Jul; 143(1):127-31. PubMed ID: 10886146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of malignant lymphoma of the skin].
    Sterry W
    Dtsch Med Wochenschr; 1988 Feb; 113(6):221-3. PubMed ID: 3276495
    [No Abstract]   [Full Text] [Related]  

  • 12. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
    Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent leukapheresis: an adjunct to low-dose chemotherapy for Sézary syndrome.
    McEvoy MT; Zelickson BD; Pineda AA; Winkelmann RK
    Acta Derm Venereol; 1989; 69(1):73-6. PubMed ID: 2563614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sustained molecular remission in an adult patient with Sézary syndrome after peripheral allogeneic stem-cell transplantation].
    Jurkovicova J; Xicoy B; Bielsa I; Arellano A
    Med Clin (Barc); 2011 Mar; 136(7):317-8. PubMed ID: 20462612
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sézary syndrome.
    Fritz TM; Kleinhans M; Nestle FO; Burg G; Dummer R
    Br J Dermatol; 1999 Jun; 140(6):1144-7. PubMed ID: 10354086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype.
    Mercieca J; Matutes E; Dearden C; MacLennan K; Catovsky D
    J Clin Oncol; 1994 Dec; 12(12):2588-93. PubMed ID: 7989933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of insulin-dependent diabetes mellitus on response to extracorporeal photopheresis in patients with Sézary syndrome.
    Bouwhuis SA; el-Azhary RA; Gibson LE; McEvoy MT; Pittelkow MR
    J Am Acad Dermatol; 2002 Jul; 47(1):63-7. PubMed ID: 12077583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sezary syndrome.
    Ali CM; Sikdar TK; Sultana N; Hoque MR; Ahmed N; Parvez Z; Kamal B; Rahman F
    Mymensingh Med J; 2011 Jul; 20(3):497-500. PubMed ID: 21804519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Sézary Syndrome With Alemtuzumab: A Series of 5 Cases and a Review of the Literature.
    del Alcázar-Viladomiu E; Tuneu-Valls A; López-Pestaña A; Vidal-Manceñido MJ
    Actas Dermosifiliogr; 2015 Sep; 106(7):e33-9. PubMed ID: 25960287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brentuximab as a treatment for CD30+ mycosis fungoides and Sézary syndrome.
    Mehra T; Ikenberg K; Moos RM; Benz R; Nair G; Schanz U; Haralambieva E; Hoetzenecker W; Dummer R; French LE; Guenova E; Cozzio A
    JAMA Dermatol; 2015 Jan; 151(1):73-7. PubMed ID: 25317818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.